PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

With four products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.

LATEST NEWS

  • UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs Global Healthcare Conference...  MORE >
  • BioMarin to Present at the Goldman Sachs Global Healthcare Conference...  MORE >
  • BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU...  MORE >